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Growth-arrested 3T3-L1 preadipocytes rapidly express
CCAAT/enhancer-binding protein- (C/EBP) upon hormo-
nal induction of differentiation. However, the DNA binding
activity of C/EBP is not activated until the cells synchronously
reenter S phase during the mitotic clonal expansion (MCE)
phase of differentiation. In this period, C/EBP is sequentially
phosphorylated by MAPK and glycogen synthase kinase-3,
inducing C/EBPDNA binding activity and transcription of its
target genes. Because the DNA binding activity of C/EBP is
further enhanced by oxidation in vitro, we investigated how
redox state affects C/EBP DNA binding and MCE during adi-
pogenesis. When 3T3-L1 cells were treated with H2O2 and hor-
monal stimuli, differentiation was accelerated with increased
expression of peroxisome proliferator-activated receptor .
Interestingly, cell cycle progression (S to G2/M phase) was
markedly enhanced by H2O2, whereas antioxidants caused an S
phase arrest during the MCE. H2O2 treatment resulted in the
early appearance of a punctate pattern observed by immunoflu-
orescent staining of C/EBP, which is a hallmark for C/EBP
binding to regulatory elements, whereas a short antioxidant
treatment rapidly dispersed the centromeric localization of
C/EBP. Consistently, reactive oxygen species production was
increased during 3T3-L1 differentiation. Our results indicate
that redox-induced C/EBP DNA binding activity, along with
the dual phosphorylation of C/EBP, is required for the MCE
and terminal differentiation of adipocytes.
Adipocyte differentiation involves an elaborate network of
transcription factors that regulate the expression of numerous
genes responsible for the phenotype of mature adipocytes
(1–3). Several members of the C/EBP2 family as well as PPAR
participate in a transcriptional cascade during adipogenesis (2,
4). Most of our knowledge about transcriptional regulation in
adipocytes comes from studies using the murine 3T3-L1 prea-
dipocytemodel. The differentiation of growth-arrested 3T3-L1
cells into adipocytes is induced by hormonal stimuli, which
immediately causes the expression of C/EBP (5–7). C/EBP is
thought to initiate mitotic clonal expansion of the preadipo-
cytes and to later coordinate the transcription network by turn-
ing on two principal adipogenic factors, C/EBP and PPAR (1,
8). Although the expression of C/EBP reaches its maximal
level within 4 h of induction, the binding of C/EBP to DNA
and the expression of C/EBP and PPAR are only observed
after a long lag period (4, 5). During this period, cells synchro-
nously enter the cell cycle (6, 9), which is accompanied by the
nuclear localization of glycogen synthase kinase 3 (GSK3)
(10).
A recent investigation has revealed that phosphorylation of
C/EBP by nuclear GSK3 enhances its DNA binding activity
(10). Thr188 of C/EBP is phosphorylated by MAPK immedi-
ately after its expression is induced and then later by GSK3 on
Ser184 or Thr179. The priming phosphorylation of C/EBP-
Thr188 is maintained throughout S phase and mitotic clonal
expansion through the activity of Cdk2-cyclin A after MAPK
activity is down-regulated (11). Because the translocation of
GSK3 into the nucleus is observed 12–14 h after induction, it
has been suggested that the dual phosphorylation of C/EBP is
associatedwith the activation of itsDNAbinding function. This
finding has been confirmed in our experiment using highly
purified recombinant C/EBP (12). In that study, when recom-
binant C/EBP protein was exposed to mild oxidizing condi-
tions, only doubly phosphorylated C/EBP had enhancedDNA
binding activity. This suggests that the dual phosphorylation of
C/EBP leads to a conformational change that facilitates di-
merization through its C-terminal leucine zipper domain, ren-
dering the basic DNA-binding region of C/EBP accessible to
the C/EBP regulatory element on C/EBP or PPAR. In this
scenario, under oxidizing conditions themonomer-dimer equi-
librium of dual phosphorylated C/EBP would be shifted
toward dimer formation and the binding of the regulatory ele-
ment to confer the proper level of transcriptional activation
(12).
Although the mechanisms by which redox state actively reg-
ulates cellular metabolism are not clear, several reports have
proposed that oxidative stress is an important element in met-
abolic diseases. For example, in obesity, fat accumulation is cor-
related with systemic oxidative stress in humans andmice (13).
Production of reactive oxygen species (ROS) increases selec-
tively in the adipose tissue of obese mice, accompanied by
increased expression ofNADPHoxidase and decreased expres-
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sion of antioxidative enzymes. In addition, increasedROS levels
are reported to be an important trigger for insulin resistance
(14). Consistent with this, it has been shown that oxidative
stress impairs glucose uptake in mature adipocytes (15) and
decreases insulin secretion from pancreatic -cells (16). ROS
generation during adipogenesis has also been observed, and it
has been proposed that insulin and insulin-like growth factor-I
are active stimulators of NADPH-dependent hydrogen perox-
ide generation (17); however, the mechanisms by which ROS
affect adipocyte differentiation have not been elucidated.
In this study, we showed how redox state affects mitotic
clonal expansion during adipocyte differentiation. H2O2 treat-
ment in conjunctionwith hormonal stimulation of 3T3-L1 cells
caused accelerated cell cycle progression (S toG2/Mphase) and
the early appearance of punctate patterns observed from the
immunofluorescent staining of C/EBP. On the other hand,
short antioxidant treatment (4 h) rapidly dispersed the centro-
meric localization of C/EBP and arrested the mitotic clonal
expansion phase, indicating that ROS production is crucial for
the mitotic clonal expansion of preadipocytes. Our findings
indicate that, in addition to the dual phosphorylation of
C/EBP, redox-induced DNA-binding of C/EBP is required
for the mitotic clonal expansion and terminal differentiation of
adipocytes.
EXPERIMENTAL PROCEDURES
Cell Culture and Induction of Differentiation—3T3-L1 and
3T3-F442A preadipocytes weremaintained inDMEMcontain-
ing 10% calf serum. To induce differentiation, 2-day postcon-
fluent 3T3-L1 cells (designated day 0) were incubated in
DMEM containing 10% FBS, 0.5 mM 3-isobutyl-1-methylxan-
thine (IBMX), 1 M dexamethasone, and 1 g/ml insulin for 2
days. For 3T3-F442A cells, differentiation was induced by 10%
FBS and 1 g/ml insulin for 2 days. Cells were then fed DMEM
containing 10% FBS and insulin for another 2 days, after which
they were fed DMEM containing 10% FBS. In some experi-
ments, H2O2 (50 or 100 M), N-acetyl cysteine (10 mM), genis-
tein (50 M), or resveratrol (50 M) was added at the time of
differentiation induction andmaintained for 2 days unless oth-
erwise stated. Cell numbers were determined on day 2, and oil
red O staining (18) was performed on day 8.
Western Blotting—At each time indicated, cells were washed
once with cold phosphate-buffered saline (PBS) and then
scraped into lysis buffer containing 1% SDS and 60 mM Tris-
HCl, pH 6.8. Lysates were boiled for 10 min and verified by
centrifugation, and then equal amounts of protein were sub-
jected to SDS-PAGE and immunoblotted with antibodies to
C/EBP (5), PPAR, cyclin A, or SIRT1 (Santa Cruz Biotech-
nology, Inc., Santa Cruz, CA).
Small Interfering RNA (siRNA)—3T3-L1 preadipocytes were
plated with DMEM containing 10% calf serum at a density of
6  105 cells/dish in 60-mm dishes. Twenty-four hours later,
mediumwas changed toOPTI-MEM (Invitrogen), and the cells
(about 70% confluent) were transfectedwith siRNAusing Lipo-
fectamine RNAi/MAX reagent (Invitrogen), according to the
manufacturer’s protocol. The next day, medium was replaced
with freshDMEMcontaining 10% calf serum for 24 h before the
induction of differentiation. The modified synthetic CEBP
siRNA (stealth siRNA) and SIRT1 siRNAwere from Invitrogen.
The sequences are as follows: siCEBP, 5-AGUAG AAGUU
GGCCA CUUCC AUGGG-3; siSIRT1, 5-GAUGA AGUUG
ACCUC CUCAT T-3.
FACS Analysis—3T3-L1 preadipocytes were induced to dif-
ferentiate, as described above. At the times indicated, cells were
trypsinized, washed with PBS, and fixed with 90% cold metha-
nol. Fixed cells werewashedwith PBS and incubated in the dark
for 30 min with propidium iodide staining solution containing
50 g/ml propidium iodide and 100 g/ml RNase A in PBS.
Labeled cells were analyzed using a FACSCalibur flow cytom-
etry system (BD Biosciences). Fluorescence was measured at
650 nm for propidium iodide, and data were analyzed using
CellQuest software (BD Bioscience).
Immunohistochemistry—3T3-L1 cells were differentiated on
coverslips in 6-well plates at the same density as usual, as
described above. At the times indicated, cells were washed with
PBS, fixed in 4% formaldehyde for 10 min, permeabilized with
0.2% Triton X-100 for 20 min on ice, and then blocked in 3%
bovine serum albumin in PBS for 1 h. Cells were then incubated
in blocking solution containing C/EBP antibody (5) (1:250
dilution) for 1 h, followed by secondary antibody (anti-rabbit
IgG-fluorescein isothiocyanate) for 1 h. The cells were
mounted in 4,6-diamidino-2-phenylindole.
Chromatin Immunoprecipitation (ChIP)—ChIP analysis was
performed following the protocol of the ChIP assay kit (Upstate
Biotechnology, Inc., Lake Placid, NY). DNA-protein complexes
were immunoprecipitated with antibodies against C/EBP for
4 h and then collectedwith proteinA-agarose for 3 h. The beads
were washed, and chromatin complexes were eluted from the
beads. After reversal of the cross-linking, DNA was purified,
and input control or ChIP samples were used as a template in
PCR using the following primers to amplify the PPAR2 pro-
moter containing the C/EBP binding site: sense, 5-TGCTA
TCCAA ATTCT ATAAA-3, antisense 5-ATTTA AATTT
TACTA GCCTT-3.
In Vitro Phosphorylation and Oxidation of Recombinant
C/EBP, EMSA, and Nonreducing SDS-PAGE—Recombinant
C/EBP protein was prepared and phosphorylated by MAPK
and GSK3, as described (12). For phosphorylation, 500 ng of
recombinant proteinwas incubatedwith activatedMAPK (Cal-
biochem) andGSK3 (Upstate Biotechnology) in 50mMHepes
(pH7.6), 10mMMgCl2, 0.5mMATP, and 1mMDTTat 30 °C for
30 min. After phosphorylation, C/EBP was treated with vari-
ous concentrations of H2O2 for 30 min, followed by 20 mM
iodoacetamide. Samples (40 ng of protein) were run in 10%
NuPAGE (Invitrogen) without reducing agent, transferred,
and subjected to immunoblotting with anti-C/EBP antibody.
EMSA was performed, essentially as described (12). In oxida-
tion-induced binding experiments, DTT was omitted unless
indicated. The C/EBP-binding sequence in the C/EBP pro-
moter is 5-GGCGT TGCGC CACGA TCTCT CT-3.
Measurement of ROS—ROS were detected with the perox-
ide-sensitive fluorophore 2,7-dichlorodihydrofluorescein
diacetate (DCF-DA) (Invitrogen). At the times indicated,
DCF-DA dissolved in DMSO was added to cells at 10 M (final
concentration). After incubation for 1 h at 37 °C under an
atmosphere including 5% CO2, 3T3-L1 cells were washed with
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PBS and resuspended in PBS. Cells were analyzed by the FAC-
SCalibur flow cytometry system (BD Biosciences). A 488-nm
argon laser beam was used for excitation. The arithmetic mean
fluorescence channel was derived by CellQuest software.
RESULTS
ROS Accelerates the Differentiation of 3T3-L1 Preadipocytes—
Postconfluent, growth-arrested 3T3-L1 preadipocytes were
induced to differentiate by hormonal stimulation. To investi-
gate whether ROS affects adipocyte differentiation, H2O2 was
added for the first 2 days (day 0 to day 2) of the standard differ-
entiation protocol. As shown in Fig. 1A, 2-day H2O2 treatment
caused enhanced differentiation, as detected by oil red O stain-
ing, which is correlated with PPAR expression. The H2O2
effect was more pronounced when a partial hormonal stimulus
(by removing insulin from the standard regimen) was used. The
3T3-L1 cell differentiation was diminished to50% of control
levels in the absence of insulin, whereas the addition of H2O2
markedly enhanced the differentiation (Fig. 1B) even in the
absence of insulin. The effect of H2O2 treatment was strongly
reproducible, dose-dependent, and observed only in differenti-
ating preadipocytes, whereas preconfluent proliferating cells
did not survive the relatively high concentration (100 M) of
H2O2 (not shown). When differentiating preadipocytes were
exposed to antioxidants, such as genistein or resveratrol,
PPAR expression was nearly abolished, and cells did not dif-
ferentiate, as shown by oil red O staining (Fig. 1A). Treatment
with the general antioxidant N-acetyl cysteine (NAC) had the
same effect on oil red O staining (Fig. 1C).
In an attempt to identify the mechanism by which H2O2
affects 3T3-L1 cell differentiation, we first investigated the
expression of C/EBP, a key regulator of C/EBP and PPAR
expression. Although PPAR expression and lipid accumula-
tion were affected by H2O2 or antioxidant treatment, the
expression of C/EBP was essentially unchanged (Fig. 1D). It
had been previously shown that mouse embryonic fibroblast
cells from C/EBP(/) mice undergo neither clonal amplifi-
cation nor terminal differentiation, indicating that C/EBP is
required for mitotic clonal expansion (6). Consistently, RNA
interference of C/EBP expression prevented the differentia-
tion of 3T3-L1 cells (Fig. 1E). Importantly, H2O2 treatment did
not result in any significant differentiationwhen the expression
of C/EBP was reduced by siRNA (Fig. 1E), confirming that
C/EBP is absolutely required for adipogenesis and also sug-
gesting that the ROS-dependent effect requires the presence of
C/EBP protein. We also attempted to confirm these findings
with the other preadipocyte precursor cell line, 3T3-F442A.
This cell line is reported to undergo clonal expansion accom-
panied by DNA synthesis and increased cell numbers (19, 20),
which means that the differentiation of 3T3-F442A would be
also affected by ROS. A similar result was observed with 3T3-
F442A (Fig. 1F), indicating that theROSeffect is not confined to
3T3-L1 cells. These findings indicate that ROS may accelerate
the differentiation process by enhancing the activation of
C/EBP.
ROS Facilitates Cell Cycle Progression into G2/M Phase dur-
ing Mitotic Clonal Expansion—Next, we examined how cell
cycle events during mitotic clonal expansion are affected by
ROS production. Upon hormonal stimulation, growth-arrested
3T3-L1 cells synchronously reenter the cell cycle, resulting in
the detection of dividing cells (G2/M) by FACS analysis after
24 h of induction (Fig. 2A). After exiting M phase, these cells
either undergo a second round of division or begin the terminal
differentiation process; therefore, induced cells are no longer
synchronous beyond 24 h of hormone stimulation (1). Interest-
ingly, H2O2 treatment caused an increase in the G2/M popula-
tion during adipocyte differentiation, in a dose-dependent
FIGURE 1. The effects of ROS on differentiation of 3T3-L1 preadipocytes.
Two-day postconfluent 3T3-L1 preadipocytes were induced to differentiate
with the standard hormonal regimen (IBMX, dexamethasone, and insulin) in
the presence or absence of H2O2 (100 M), genistein (50 M), resveratrol (50
M) (A), orN-acetyl cysteine (10mM) (B). After 2 days, all groups were fedwith
FBS,DMEM, and insulin for another 2days and thenwithFBSDMEM.Onday
8, cells were fixed, and cytoplasmic triglyceride was stained with oil red O. In
addition, whole cell extracts from day 1, 2, and 3 adipocytes were prepared
and subjected to immunoblottingwith antibody against PPAR. C, cells were
differentiated under the standard regimen (IBMX, dexamethasone, and insu-
lin; MDI) or an incomplete regimen, lacking insulin (MD). D, cell lysates pre-
pared from differentiating preadipocytes were subjected to SDS-PAGE and
immunoblotted with antibody against C/EBP. LAP and LIP, 38-kDa liver-ac-
tivating protein and 18-kDa liver-inhibiting protein, respectively. E, 3T3-L1
cells were treated with C/EBP siRNA at about 70% confluence using Lipo-
fectamine RNAi/MAX reagent. After 24 h, medium was replaced with fresh
DMEM containing 10% calf serum for 24 h before the induction of differenti-
ation. Knockdown of C/EBPwas verified by immunoblotting, and cells were
differentiatedwithorwithoutH2O2 (2-day treatment) and subjected tooil red
O staining at day 8. F, 3T3-F442A cells were differentiated in the presence or
absence of H2O2 (10M), genistein (50M), epigallocatechin 3-gallate (EGCG;
50 M), or N-acetyl cysteine (10 mM).
ROS in Adipocyte Differentiation
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manner (Fig. 2A). In contrast, genistein or resveratrol treat-
ment significantly delayed the progression of the cell cycle, sug-
gesting that ROS production is required for clonal expansion
during adipogenesis. Importantly, preadipocytes treated with
antioxidants were still in S phase after 24 h (Fig. 2B), indicating
that ROS production is specifically required for progression of
these cells from S to G2/M. Consistently, short term antioxi-
dant treatment after 16 h of induction (after cells have already
entered S phase) completely blocked the progression of cells
into G2/M phase by 24 h (Fig. 2C). These findings indicate that
ROS production is critical for the S to G2/M transition during
the mitotic clonal expansion of the adipocyte differentiation
process. Arresting or delaying cell cycle progression resulted in
decreased cell numbers at 2 days of induction compared with
control group (Fig. 3A). The cell cycle delay was also confirmed
by assaying the expression of cyclin A, as shown in Fig. 3B. We
also determined that expression of MAPK-p, MAPK, GSK3,
p27, p21, cyclin E, and Cdk2 were not significantly changed by
these treatments (data not shown). It should be noted that
although it resulted in accelerated cell cycle progression, H2O2
treatment did not lead to an increase in cell number after
clonal amplification, suggesting that there may be spatial
constraints regulating the termination of clonal expansion.
Nevertheless, our observations during the first 24-h period
FIGURE 2. FACS analysis duringMCEof adipocyte differentiation.Cells were induced to differentiate in the presence or absence of H2O2, genistein (50M),
or resveratrol (50 M), and at the times indicated, cells were trypsinized and fixed. Changes in DNA content were analyzed by FACS using a FACSCalibur flow
cytometry system, anddatawere analyzed usingCellQuest software. FACS analysiswas performedduring 0–72 hof differentiation induction (A) and after 24 h
of induction (B). C, cells were differentiated with the standard protocol for 16 h, after which resveratrol (50 M) was added to the medium. FACS analysis was
done at 24 h after induction of differentiation.
FIGURE 3.Effects of ROSon cell number andexpressionof cyclinAduring
MCE.A, onday2ofdifferentiation, cellswere trypsinizedand subjected to cell
counting. Cells were treatedwithH2O2 (100M), resveratrol (50M), or genis-
tein (50 M) for 48 or 32 h, as indicated. B, cell lysates were prepared at the
times indicated and subjected to SDS-PAGE and immunoblotting (IB) to
measure the expression of cyclin A.
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of mitotic clonal expansion, during which cells are highly
synchronous, indicate that ROS production is important for
the progression of mitotic clonal expansion during adipocyte
differentiation.
ROS Production Is Associated with the Activation of C/EBP—
Previous investigations have shown that C/EBP is required
first for initiatingmitotic clonal expansion and later for activat-
ing the expression of pleiotropic transcription factor, C/EBP,
and PPAR (6). Despite the early appearance of C/EBP pro-
tein after the induction of differentiation, it does not bind to
target sites on DNA until cells enter S phase. As C/EBP
acquires its DNA binding activity, it becomes localized to cen-
tromeres, resulting in a characteristic “punctate” pattern in
immunofluorescence studies (Fig. 4A) (5). This pattern is
observed from 12 to 16 h postinduction (i.e. S phase) when
C/EBP is subjected to a second phosphorylation event by
nuclear GSK3 (10). Since we have previously reported that the
binding activity of C/EBP is further enhanced in an oxidative
environment, in vitro (12), we assumed that C/EBP binding to
centromeres would be altered by changes in ROS production
during adipogenesis. As shown in Fig. 4A, the immunofluores-
cent staining pattern of C/EBP remained diffuse at the 16 h
time point when differentiating cells were treated with resvera-
trol. The same effect was observed when the general antioxi-
dantNACwas used (Fig. 4B).More importantly, the addition of
resveratrol or NAC after 14 h, at which time C/EBP is already
localized to centromeres, rapidly converted the normal punc-
tate pattern to a diffuse nuclear staining pattern (Fig. 4, A and
B). This indicates that in the presence of appropriate oxidative
stress, the equilibrium of C/EBP binding is shifted toward
tight DNA binding, giving rise to a punctate pattern. In other
words, when oxidative stress is removed with antioxidants,
C/EBP does not readily bind to DNA despite having been
activated by dual phosphorylation. To verify the ROS ef-
fect directly, we performed immunofluorescent stainings of
C/EBP after the addition of H2O2 in 2-h time intervals
between 10 and 16 h postinduction. In the standard differenti-
ation protocol, cells began to have punctate patterns of C/EBP
between 14 and 16 h postinduction, whereas H2O2 treatment
caused the early appearance of the punctate pattern at around
12 h (Fig. 4C). This strongly suggests that in the presence of
proper ROS production, after dual phosphorylation, C/EBP
protein binds to DNA well enough to allow its centromeric
localization.
C/EBP is responsible both for mitotic clonal expansion
and the activation of the promoters of specific genes, such as
C/EBP and PPAR. To assay C/EBP binding to specific
promoters, we next performed the ChIP assays in the ab-
sence or presence of H2O2 treatment. As illustrated in Fig.
5A, H2O2 treatment caused increased binding of C/EBP to
the PPAR2 promoter (1.5- and 2.9-fold at day 1 and 2, respec-
tively), whereas resveratrol treatment decreased C/EBP bind-
ing, demonstrating that C/EBP binding to its target sites is
enhanced by ROS production. The enhanced DNA binding
activity of C/EBP in response to H2O2 treatment was also
assessed in vitro in EMSAs using recombinant C/EBP protein.
We had previously produced highly purified recombinant
C/EBP protein using the GST fusion method and ion
exchange chromatography and had confirmed the dual phos-
phorylation of the recombinant C/EBP protein byMAPK and
GSK3 (12). As had previously been shown using oxidized glu-
tathione (12), H2O2 treatment caused the dimerization of
dually phosphorylated recombinant C/EBP protein, as de-
tected by nonreducing SDS-PAGE. H2O2 treatment also
resulted in increased C/EBP DNA binding activity in the
EMSAs (Fig. 5B). These results provide evidence that C/EBP
binding to its regulatory element is enhanced by ROS, which
might occur during normal differentiation of 3T3-L1 cells, in
vivo.
ROS Production Is Increased during Mitotic Clonal Ex-
pansion—Because oxidative stress has been highlighted in
many pathologic conditions, there have been several
attempts to measure ROS production in mature adipocytes
(13, 17). However, ROS production has not specifically been
measured during the mitotic clonal expansion of differenti-
ating adipocytes. The results shown above suggest that ROS
are required for the proper differentiation of preadipocytes
and predict that ROS production should be a normal part of
the differentiation program. Since the FACS data showed
that the ROS effect was particularly important between 12
and 24 h after induction (Fig. 2), we measured intracellular
ROS levels with DCF-DA using the FACSCalibur flow
cytometry system during this time window. As shown in Fig.
6A, ROS production was significantly elevated during
FIGURE 4. Effects of ROS on intracellular localization of C/EBP during
MCE. 3T3-L1 preadipocytes were induced to differentiate with the standard
protocol in the presence or absence of H2O2 (100 M), resveratrol (50 M), or
N-acetyl cysteine (10 mM), as indicated. Cells were fixed and subjected to
immunofluorescence analysis with antibody against C/EBP and 4,6-dia-
midino-2-phenylindole. Fluorescence images were obtained by confocal
microscopy. Resveratrol (A) and N-acetyl cysteine (B) prevented the charac-
teristic punctate pattern at 16 h of induction and also rapidly dispersed the
centromeric localization after short term treatment (14–18 h of induction).
C, H2O2 caused the early appearance of a punctate pattern in immunofluo-
rescent stainings.
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mitotic clonal expansion in adipogenesis. Also, intracellular
ROS was suppressed by the addition of antioxidants, such as
genistein, resveratrol (Fig. 6A), or NAC (data not shown). It
is noteworthy that ROS production peaks during the 12–16 h
period, then decreases. We also observed that ROS produc-
tion increases in almost a linear fashion between 0 and 12 h
(data not shown), suggesting that ROS production is a direct
response to hormonal stimulation and reaches a threshold,
after which C/EBP binds to DNA effectively. We next
examined which component of the standard hormonal regi-
men for differentiation is responsible for elevating ROS lev-
els. As shown in Fig. 6B, although it appears that all of the
components (IBMX, dexamethasone, and insulin) are
required for full elevation of ROS in adipocytes, insulin may
be particularly important.
Affect of Resveratrol on Mitotic Clonal Expansion Is Inde-
pendent of the SIRT Pathway—The results illustrated in Fig. 2C
show that resveratrol blocked cell cycle progression of induced
preadipocytes at the S to G2/M transition. Apart from its anti-
oxidant activity, resveratrol has been implicated as a SIRT1
activator in regulating glucose metabolism, lipid metabolism,
and the longevity of organisms (21, 22). Although we had con-
firmed that most of our data using resveratrol can be repro-
duced using a general antioxidant NAC, we could not rule out
the possible involvement of the SIRT1 pathway. To assess
whether SIRT1 is involved in themodulation of the cell cycle by
ROS, we carried out FACS analysis with or without RNA inter-
ference to reduce SIRT1 expression. As shown in Fig. 7A, the
blocking of the S to G2/M transition by resveratrol was not
influenced by SIRT1 knockdown. Moreover, sirtinol, an inhib-
itor of SIRT1 (23), neither affected the progression of clonal
expansion, as assessed by FACS (data not shown), nor modu-
lated ROS production during mitotic clonal expansion (Fig.
7B), suggesting that resveratrol affects the cell cycle of differen-
tiating adipocytes in a SIRT1-independent manner, at least
during the mitotic clonal expansion phase of adipogenesis.
Meanwhile, some investigators have suggested that AMP-de-
pendent kinase is a downstream target of resveratrol (22, 24,
25). Ithasalsobeensuggested thatpersistentactivationofAMP-
dependent kinase inhibits adipocyte differentiation (26, 27). In
our experiments, aminoimidazole carboxamide ribonucleotide
treatment did not change the level of ROS production in
3T3-L1 cells (Fig. 7B), indicating thatAMP-dependent kinase is
not involved in ROS production during adipogenesis. This does
not rule out the possibility that increased ROS production dur-
ing mitotic clonal expansion down-regulates AMP-dependent
kinase activity, as has been proposed by another group (26);
however, it does confirm that resveratrol inhibitsmitotic clonal
expansion by modulating ROS production, independent of the
SIRT1 and AMP-dependent kinase pathways.
DISCUSSION
The differentiation of 3T3-L1 preadipocytes is triggered by
hormonal agents and carried out by the coordination and pre-
FIGURE 5.DNA-binding of C/EBP protein, in vivo and in vitro. A, chroma-
tin immunoprecipitation (IP) analysis using the PPAR promoter. At the indi-
cated times after inductionof differentiationwithorwithoutH2O2 (100M)or
resveratrol (50 M), cells were cross-linked with formaldehyde, the DNA was
fragmented, and the chromatin-associated DNA was immunoprecipitated
with IgG or antibodies against C/EBP. PCR amplification of the DNA frag-
ments was conducted with specific primers corresponding to the PPAR2
promoter sequence. Relative -fold changes of binding were calculated
using a densitometer. B, EMSA of recombinant C/EBP protein treated by
H2O2. Recombinant protein doubly phosphorylated by MAPK and GSK3
was treated with the indicated concentrations of H2O2 and/or 5 mM DTT
and subjected to nonreducing SDS-PAGE, without DTT, and immunoblot-
ting (IB) with anti-C/EBP antibody (top). The same reaction using 1 mM
H2O2 was used for EMSA, except the reaction was terminated with 20 mM
iodoacetamide at the indicated times, and 5 ng of protein was used for the
binding reaction with the C/EBP site (bottom). DTT was added as marked
(0–5 mM).
FIGURE6.ROSproductionduringMCE inadipogenesis.ROSweredetected
with the peroxide-sensitive fluorophore DCF-DA. At the times indicated, cells
were incubatedwithDCF-DA (10M) for 1 h and analyzedby the FACSCalibur
flow cytometry system; data are presented as relative intracellular ROS levels.
A, ROS levels duringMCE in the presence or absence of H2O2 (100M), genis-
tein (50M), or resveratrol (50M); B, 3T3-L1 preadipocyteswere treatedwith
IBMX (M), dexamethasone (D), or insulin (I), respectively; ROS productionwas
measured, as described above.
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cise control of transcriptional cascades. The first stage of adi-
pocyte differentiation is growth arrest at a confluent state (28),
and proliferating cells will not accumulate lipid droplets in their
cytoplasms, even in the presence of hormonal stimulation, until
they become confluent. Upon induction of differentiation,
growth-arrested cells undergo additional rounds of cell divi-
sion, known as mitotic clonal expansion (1). Other preadipo-
cyte lineages, such as 3T3-F442A and Ob17 cells, like 3T3-L1
cells, are also believed to undergo a clonal amplification proc-
ess, since inhibition of DNA synthesis prevents the differentia-
tion of these cells (29). On the other hand, primary preadipo-
cytes derived from human adipose tissue have been reported to
differentiate even in the presence of alkylating agents that
inhibit mitosis (30). It is uncertain whether primary preadipo-
cytes prepared from human fat pads have already undergone
mitotic clonal expansion in vivo (28, 29). It isworth pointing out
that the mitotic clonal expansion after the confluent stage dif-
fers from the cell divisions that occur during the proliferation
stage (5), especially in regard to the use of activating genes, such
as PPAR andC/EBP, after growth arrest, suggesting that crit-
ical events may take place between mitotic clonal expansion
and terminal differentiation. Hence, it is important to investi-
gate how themolecular events duringmitotic clonal expansion,
whether or not they are related to cell cycle, are associated with
terminal differentiation as well as with the expression of
C/EBP and PPAR.
C/EBP is one of the critical transcription factors expressed
during the mitotic clonal expansion period (4). During adipo-
cyte differentiation, C/EBP is immediately expressed upon
hormonal stimulation and sequentially phosphorylated by
MAPK and GSK3 (5, 10). C/EBP lacks DNA binding activity
until the protein is phosphorylated by GSK3 at 12–16 h after
induction (10). At this time, C/EBP becomes localized to cen-
tromeres as preadipocytes synchronously enter S phase at the
onset of mitotic clonal expansion (5). Because the localization
to centromeres occurs through C/EBP consensus-binding sites
in centromeric satellite DNA, it is
thought that the C/EBP becomes
active only after dual phosphoryla-
tion by MAPK and GSK3,
although the maximal expression of
C/EBP is much earlier (4 h after
induction). Previously, we were able
to assess how C/EBP becomes
activated by dual phosphorylation
using highly purified recombinant
C/EBP protein (12). A model was
proposed inwhich dual phosphoryl-
ation of C/EBP caused a confor-
mational change that facilitates S–S
bond formation and dimerization,
rendering the basic region accessi-
ble to the C/EBP regulatory ele-
ment. In this point of view, we
hypothesized that differentiating
cells are exposed to an oxida-
tive environment, which enhances
C/EBP function during adipogen-
esis, in vivo. In the present study, we show that adipogenesis is
accelerated by increasing ROS levels, which are related to
C/EBP DNA binding activity. ROS production is increased
during adipogenesis induced by the standard protocol, partic-
ularly within 12–16 h after differentiation induction (Fig. 6).
This period corresponds to the S phase of the mitotic clonal
expansion, during which C/EBP localizes to centromeres.
Interestingly, reducing ROS levels by antioxidant treatment
preventednot only the localization ofC/EBPbut also cell cycle
progression into G2/M phase. Although this is not absolute
proof that C/EBP is directly involved in the S to G2/M transi-
tion, it should be noted that short term antioxidant treatment
dispersed the centromeric localization of C/EBP, in addition
to blocking S to G2/M progression, showing that the activation
of C/EBP is at least associated with cell cycle progression. It
should be noted that although C/EBP is reported to be crucial
for adipogenesis in 3T3-L1 cells and mouse embryonic fibro-
blasts from C/EBP(/) mice (6), its absolute requirement
was argued by other experiments (31). Also, C/EBP-deficient
mice have some adiposity, probably due to abnormal lipogene-
sis (31). In this regard, it was suggested that C/EBPmay com-
pensate for the loss of C/EBP, with some redundancy in the
early steps of adipogenesis in vivo (2, 32). It remains to be clar-
ified whether the ROS effect on C/EBP is related to adipogen-
esis in vivo, which is also associated with controversy about the
requirement of mitotic clonal expansion in vivo (28, 29).
Oxidative stress has been implicated in various diseases,
including insulin resistance, obesity, cardiovascular disease,
and type 2 diabetes (13–16). Furukawa et al. (13) have reported
that increased oxidative stress in accumulated fat is an impor-
tant pathogenic mechanism of obesity-associated metabolic
syndrome. ROSwere also reported to have a causal role inmul-
tiple forms of insulin resistance (14). On the other hand, glu-
cose 6-phosphate dehydrogenase is proposed to enhance pro-
oxidative enzymes, including iNOS and NADPH oxidase, thus
inducing oxidative stress in mature adipocytes (33). Our data
FIGURE 7. Resveratrol effects are independent of SIRT1 pathway. A, 3T3-L1 preadipocytes were subjected
toRNA interference against siSIRT1. A50% reductionof SIRT1expressionwas confirmedbyWesternblotting,
and FACS showed that SIRT1 knockdowndid not affect the S phase accumulation of cells driven by resveratrol.
B, ROSmeasurement duringMCE from cells treatedwith aminoimidazole carboxamide ribonucleotide (AICAR)
(1 mM) or sirtinol (20 M).
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show that ROS are also important in regulating mitotic clonal
expansion during adipogenesis, supported by the experiments
in which H2O2 or antioxidant treatment was added only for the
first 2 days of the differentiation protocol. Given that in obese
animals mature adipocytes produce higher levels of ROS com-
pared with other tissues, including liver, skeletal muscle, and
aorta (13), it is possible that mature adipocytes could be major
sources of ROS, accelerating the differentiation of adjacent
preadipocytes. Therefore, obesity could be aggravated by the
vicious cycle of “adipocyte hypertrophy 3 increased local
ROS3 adipocyte hyperplasia.”
Although we did not identify the intracellular source of ROS
duringMCE, we did show that insulinmay be important for the
elevation of ROS levels (Fig. 6B). Because preadipocytes do not
express insulin receptor until 3 days of induction (34, 35),
insulin-like growth factor-I signaling may be responsible for
increased ROS production. In this regard, it should be noted
that removing insulin from the standard differentiation regi-
men (FBS  IBMX, dexamethasone, and insulin) caused S
phase arrest of the mesenchymal stem cell line, C3H10T1/2
(36). Consistently, our experiments also show that the reduc-
tion in differentiation seen when incomplete hormonal stimu-
lation (IBMX dexamethasone) was usedwas largely compen-
sated by H2O2 treatment (Fig. 1C). This strongly suggests that
preadipocytes are stimulated to produce ROS by insulin-like
growth factor-I signaling, resulting in the full DNA-binding
capacity of C/EBP to complete the clonal expansion. Recently,
Friedman and colleagues (37) reported that xanthine oxi-
doreductase is a regulator of adipogenesis and that xanthine
oxidoreductase functions downstream of C/EBP and up-
stream of PPAR. Since exogenous xanthine oxidase is com-
monly used to induce oxidative damage by increasing superox-
ide in experimental models, it would be interesting to
investigate how xanthine oxidoreductase is regulated by insu-
lin-like growth factor-I signaling as well as how xanthine oxi-
doreductase affects cell cycle progression in 3T3-L1 cells.
In another study, we have shown that in vitro oxidation of
C/EBP protein markedly enhances the DNA binding activity
by S–S bond formation and conformational change (12).
Although any direct disulfide bond formation is evident in vivo,
there is increasing evidence for redox regulation of transcrip-
tion factors. For example, cysteine 179 of the inhibitory B
kinase  subunit is reported to be a target of oxidative inactiva-
tion bymeans of S-glutathionylation (38). In addition, the c-Jun
transcription factor is regulated by redox change, which is spe-
cifically targeted to the cysteine residue located in the DNA
binding site of the protein (39).More interesting data have been
reported for the Stat3 transcription factor (40, 41). This protein
is activated by a single tyrosine phosphorylation in response to
extracellular ligand, resulting in dimerization, DNA binding,
and transactivation of specific target genes. Interestingly, sub-
stitution of two cysteine residues within the C-terminal region
of Stat3 resulted in the spontaneous activation of the transcrip-
tion factor, creating a constitutive active form of the protein
(40). This means that cysteine residues in each molecule, when
in close proximity, help bind to the partner molecule tightly.
Still, it is doubtful whether disulfide bonds form in the relatively
reducing milieu of nuclei; however, it has been suggested that
dynamic cysteine-cysteine interactions are possible, as evi-
denced by the Pax transcription factor (42). In the present
study, the DNA binding activity of C/EBP is enhanced in the
presence of H2O2, as evidenced by immunofluorescent staining
(Fig. 4C) as well as EMSA and ChIP assays (Fig. 5), providing an
example of a transcription factor that may be regulated by
redox changes in vivo.
C/EBP is required for the mitotic clonal expansion during
adipocyte differentiation (4) and for liver regeneration (43),
inflammation processes or the acute phase reaction (44), and
cellular proliferation (45). Thus, it will be interesting to inves-
tigate whether C/EBP activation in these physiological pro-
cesses is caused by subtle changes of cellular redox state.
Explaining how C/EBP family proteins interact together in dif-
ferent combinations in various situations will be important for
the understanding of these physiological processes.
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